Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Awd 131-138
2. Awd131-138
3. Elb138
4. Pexion
1. 188116-07-6
2. Awd 131-138
3. Imepitoin [inn]
4. Imepition
5. Awd131-138
6. 1-(4-chlorophenyl)-4-morpholin-4-yl-5h-imidazol-2-one
7. 2h-imidazol-2-one, 1-(4-chlorophenyl)-1,5-dihydro-4-(4-morpholinyl)-
8. Add-233089
9. Awd-131-138
10. 1-(4-chlorophenyl)-4-morpholino-1h-imidazol-2(5h)-one
11. Imepitoin (awd 131-138)
12. Elb-138
13. 1-(4-chlorophenyl)-1,5-dihydro-4-(4-morpholinyl)-2h-imidazol-2-one
14. 19v39682li
15. Pexion
16. 1-(4-chlorophenyl)-4-(morpholin-4-yl)-2,5-dihydro-1h-imidazol-2-one
17. 3-(4-chlorophenyl)-5-morpholin-4-yl-4h-imidazol-2-one
18. Unii-19v39682li
19. Imepitoin [mi]
20. Awd 131-138(imepitoin)
21. Chembl204240
22. Schembl1645360
23. Zinc6856
24. Dtxsid50172160
25. Ex-a261
26. Hms3886o19
27. Bcp08396
28. Mfcd18450225
29. S5319
30. Akos024258133
31. Ccg-267239
32. Cs-1733
33. Imepitoin [ema Epar Veterinary]
34. Ncgc00371144-02
35. Ncgc00371144-03
36. Ac-36287
37. As-72354
38. Da-33561
39. Hy-14953
40. Ft-0700248
41. J3.500.192a
42. A13726
43. J-690252
44. Q27252133
45. 1-(4-chlorophenyl)-4-(morpholin-4-yl)-1,5-dihydro-2h-imidazol-2-one
Molecular Weight | 279.72 g/mol |
---|---|
Molecular Formula | C13H14ClN3O2 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 279.0774544 g/mol |
Monoisotopic Mass | 279.0774544 g/mol |
Topological Polar Surface Area | 45.1 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 374 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options.
QN03AX90
VMF Number : 5980
Submission : 2010-04-13
Status : Active
Type : II
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
About the Company : Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API...
ABOUT THIS PAGE
A Imepitoin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imepitoin, including repackagers and relabelers. The FDA regulates Imepitoin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imepitoin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imepitoin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imepitoin supplier is an individual or a company that provides Imepitoin active pharmaceutical ingredient (API) or Imepitoin finished formulations upon request. The Imepitoin suppliers may include Imepitoin API manufacturers, exporters, distributors and traders.
click here to find a list of Imepitoin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imepitoin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imepitoin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imepitoin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imepitoin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imepitoin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imepitoin suppliers with NDC on PharmaCompass.
Imepitoin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imepitoin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imepitoin GMP manufacturer or Imepitoin GMP API supplier for your needs.
A Imepitoin CoA (Certificate of Analysis) is a formal document that attests to Imepitoin's compliance with Imepitoin specifications and serves as a tool for batch-level quality control.
Imepitoin CoA mostly includes findings from lab analyses of a specific batch. For each Imepitoin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imepitoin may be tested according to a variety of international standards, such as European Pharmacopoeia (Imepitoin EP), Imepitoin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imepitoin USP).
LOOKING FOR A SUPPLIER?